Louis M. Staudt, M.D., Ph.D.
Biography: Dr. Staudt received his B.A. from Harvard College in
1976 and his M.D. and Ph.D. from the University of
Pennsylvania in 1982. His Ph.D. thesis in the laboratory of
Walter Gerhard defined somatic hypermutation as a specialized
mechanism of antibody diversification. Following Internal
Medicine training, he joined David Baltimore's laboratory where
he cloned and characterized the lymphoid-restricted transcription
factor Oct-2. He established his laboratory in the Metabolism
Branch, NCI, in 1988, and currently studies the molecular basis
of human lymphoid malignancies.